Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative.

MLA

Auguste, Aurélie, et al. “Refinement of High-Risk Endometrial Cancer Classification Using DNA Damage Response Biomarkers: A TransPORTEC Initiative.” Modern Pathology, vol. 31, no. 12, Dec. 2018, pp. 1851–61. EBSCOhost, https://doi.org/10.1038/s41379-018-0055-1.

APA

Auguste, A., Genestie, C., De Bruyn, M., Adam, J., Le Formal, A., Drusch, F., Pautier, P., Crosbie, E. J., MacKay, H., Kitchener, H. C., Powell, M., Pollock, P. M., Mileshkin, L., Edmondson, R. J., Nout, R., Nijman, H. W., Creutzberg, C. L., Bosse, T., & Leary, A. (2018). Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative. Modern Pathology, 31(12), 1851–1861. https://doi.org/10.1038/s41379-018-0055-1

Chicago

Auguste, Aurélie, Catherine Genestie, Marco De Bruyn, Julien Adam, Audrey Le Formal, Françoise Drusch, Patricia Pautier, et al. 2018. “Refinement of High-Risk Endometrial Cancer Classification Using DNA Damage Response Biomarkers: A TransPORTEC Initiative.” Modern Pathology 31 (12): 1851–61. doi:10.1038/s41379-018-0055-1.